GLP-1 ( Glucagon-Like Peptide-1 ) is a hormone secreted by L cells, mainly in the intestine, which: The role of this hormone in regulating appetite makes it a key element in weight-loss therapies
To keep patients safe and outcomes strong, consider the following clinical best practices: Start low, go slow on dosing Monitor for GI symptoms, especially early on Revisit mental health and vision concerns routinely Avoid use in patients with thyroid cancer history Stay alert for signs of pancreatitis or gallbladder issues Smart oversight matters
Topical imiquimod therapy is an immune response modifier that may be used to treat some basal cell carcinomas and is applied to the skin as a cream
Long-Term Results: Unlike quick-fix solutions, medical weight loss treatments provide gradual, sustainable progress tailored to each individual
Your BMI is 27 or higher and you have a weight-related medical condition, like sleep apnea, Type 2 diabetes, or heart disease